Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler

NCT04534660 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sofregen Medical, Inc.

Collaborators